Cleared Special

K141146 - INVISIPORT

K141146 is an FDA 510(k) clearance for INVISIPORT, manufactured by Stealth Therapeutics, Incorporated. The device is a Class 2 General Hospital device with product code LJT cleared through the Special 510(k) pathway after a 361-day FDA review.

K141146 · Stealth Therapeutics, Incorporated · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
May 2015
Decision
361d
Days
Class 2
Risk

K141146 is an FDA 510(k) clearance for the INVISIPORT. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Stealth Therapeutics, Incorporated (Stoughton, US). The FDA issued a Cleared decision on May 1, 2015 after a review of 361 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Elevated predicate reliance profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K141146

510(k) Number K141146 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 2014
Decision Date May 01, 2015
Days to Decision 361 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
232d slower than avg
Panel avg: 129d · This submission: 361d
Pathway characteristics
Modification to existing cleared device.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 254
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K141146.
NMI Port, NMI Port II
K153228 · Navilyst Medical, Inc. · Dec 2015
Power-Injectable Implantable Ports with ChronoFlex Polyurethane Catheters
K150514 · C.R. Bard, Inc. · Nov 2015
Vital-Port Vascular Access System Power Injectable Port
K150733 · Cook Incorporated · May 2015
VITAL-PORT(R) CT VASCULAR ACCESS SYSTEM
K140169 · Cook Incorporated · May 2014
POWERPORT IMPLANTABLE PORT
K133335 · C.R. Bard, Inc. · Feb 2014
MEDCOMP GEN III POWER INJECTABLE PORT
K132177 · Medcomp ( Medical Components) · Dec 2013
K141146 · INVISIPORT
Download PDF FDA Summary Stealth Therapeutics,…